Clinical Trials Browser

Phase 3 × lutetium Lu 177 dotatate × Clear all

NCT03972488 2026-01-21

NETTER-2

Phase 3 Active not recruiting

226 enrolled 14 charts

EndocrineGastrointestinalNET

Gastro-enteropancreatic neuroendocrine tumor

NCT06878664 2025-09-02

RIALTO

Phase 3 Recruiting

Neuroendocrine Tumors

NCT01842165 2022-11-10

LUMEN

Phase 3 Completed

Neuroendocrine Tumors

NCT01578239 2022-04-04

NETTER-1

Phase 3 Completed

231 enrolled 16 charts 2 FDA

Neuroendocrine Tumors

NCT01860742 2016-04-05

CASTOR

Phase 3 Withdrawn

Neuroendocrine Tumors